Back to CLDX

Elmind Capital, LP → CLDX

Elmind Capital, LP CLDX Position History

Celldex Therapeutics, Inc.

Quarters held
4
Latest value
$36M
Q3 2026
Peak value
$36.8M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$23.5M
Q1 2026$27.4M
Q2 2026$36.8M
Q3 2026$36M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$36M1.11M——
Q2 2026$36.8M990.0K——
Q1 2026$27.4M865.0K——
Q4 2025$23.5M865.0K——

Other funds holding CLDX

Other Elmind Capital, LP positions

COGT

COGENT BIOSCIENCES INC

$45.3M
COGT

COGENT BIOSCIENCES INC

$45.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$43.3M
COGT

COGENT BIOSCIENCES INC

$41.6M
SNDX

SYNDAX PHARMACEUTICALS INC

$40.6M
SNDX

SYNDAX PHARMACEUTICALS INC

$39M
LEGN

LEGEND BIOTECH CORP

$31.2M
SNDX

SYNDAX PHARMACEUTICALS INC

$30.2M